Kudo T, Hashimoto M, Uchino T, Osada T, Furukawa K
Department of Cardiovascular Surgery, Hachioji Medical Center, Tokyo, Japan.
Artery. 1992;19(6):344-52.
Warfarin administered to patients with valve replacement at a dose of 0.1 mg/kg for 2 days after surgery, and blood levels of warfarin, TT, PT, HPT, total vitamin K and vitamin K1-epoxide were determined at various time intervals after the administration of the drug. The measurements were obtained from 15 patients: 8 patients with AVR, 6 patients with MVR, and 1 patient with DVR. The blood levels of warfarin reached a peak of 462 +/- 160 ng/ml 6 hours after the administration, TT, PT and HPT were 40% of the initial values 24 hours after the administration, and vitamin K1-epoxide was 1.28 +/- 0.30 ng/ml 24 hours after the administration. It is clear from the results that warfarin exhibits sufficient anticoagulant effects at a beginning dose of 0.1 mg/kg after surgery to prevent a sudden decrease in blood coagulation.
给瓣膜置换患者术后2天服用华法林,剂量为0.1mg/kg,并在给药后的不同时间间隔测定华法林血药浓度、凝血酶时间(TT)、凝血酶原时间(PT)、肝促凝血酶原激酶试验(HPT)、总维生素K及维生素K1-环氧化物。测量数据来自15例患者:8例行主动脉瓣置换术(AVR),6例行二尖瓣置换术(MVR),1例行双瓣膜置换术(DVR)。给药后6小时,华法林血药浓度达到峰值,为462±160ng/ml;给药后24小时,TT、PT和HPT为初始值的40%;给药后24小时,维生素K1-环氧化物为1.28±0.30ng/ml。结果表明,术后起始剂量为0.1mg/kg的华法林具有足够的抗凝作用,可防止凝血功能突然下降。